Scribe Therapeutics, Inc.SCTX
Price (close)
$21.61
Market cap
$409.1M
P/E
—
Revenue (FY)
—
Net income
—
Dividend yield
—
1-year total return
—
Net margin
—
Revenue growth
—
Debt / equity
—
What Scribe Therapeutics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2024 | 2025 |
|---|
More on SCTX.
- Scribe Therapeutics, Inc. summary
- Scribe Therapeutics, Inc. financial statements
- Scribe Therapeutics, Inc. key metrics
- Scribe Therapeutics, Inc. health scores and style box
- Scribe Therapeutics, Inc. earnings
- Scribe Therapeutics, Inc. dividends
- Scribe Therapeutics, Inc. valuation
- Scribe Therapeutics, Inc. ownership and insiders
- Scribe Therapeutics, Inc. peers
Figures from Scribe Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.